Quarterly Activity Report and Appendix 4C

• LDAi selected for COPD detection in U.S. Veterans Affairs network
• Bipartisan bill in U.S. directs VA to use 4D functional lung imaging
• SimonMed completes CT:VQ rollout across 125 sites
• Stanford Medicine renews software agreement for CT:VQ
• Record quarterly scan volume of 119,672

4DMedical Limited, a global leader in respiratory imaging technology, has released its Quarterly Activity Report for Q1 FY27. The company reported a five-year agreement with a major U.S. Veterans Affairs healthcare network for COPD detection using its LDAi technology. Additionally, a bipartisan bill in the U.S. House of Representatives aims to establish a pilot program using 4D functional lung imaging. SimonMed completed its network-wide rollout of CT:VQ and LDAf across its U.S. imaging network, and Stanford Medicine renewed its software agreement for CT:VQ. 4DMedical also secured a significant commercial win in Germany through contextflow for a lung cancer screening deployment led by Curagita. The company achieved a record quarterly scan volume of 119,672, with its global install base expanding to 724 sites.

Operating revenue of $2.3 million for Q1 FY27, up 66% on pcp

4DMedical is well-positioned to accelerate product development and pursue key strategic opportunities with a cash balance of $242.8 million.